Single-cell-led drug repurposing for Alzheimer’s disease

Alzheimer’s disease is the most common form of dementia. Notwithstanding the huge investments in drug development, only one disease-modifying treatment has been recently approved. Here we present a single-cell-led systems biology pipeline for the identification of drug repurposing candidates. Using...

Descripción completa

Detalles Bibliográficos
Autores principales: Parolo, Silvia, Mariotti, Federica, Bora, Pranami, Carboni, Lucia, Domenici, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816180/
https://www.ncbi.nlm.nih.gov/pubmed/36604493
http://dx.doi.org/10.1038/s41598-023-27420-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816180/
https://www.ncbi.nlm.nih.gov/pubmed/36604493
http://dx.doi.org/10.1038/s41598-023-27420-x

Ejemplares similares